How Big Is the Automated IV Pumps Market? Size, Share & Forecast 2033

Automated IV Pumps by Application (Hospital, Clinic, Laboratory, Others), by Types (Volumetric Infusion Pumps, Syringe Infusion Pumps, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Automated IV Pumps Market Size | CAGR 7.5 Forecast 2033

How Big Is the Automated IV Pumps Market? Size, Share & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Automated IV Pumps Market Overview

Automated IV pumps are programmable infusion devices that deliver precise medication volumes without manual intervention, essential for critical care, oncology, and home‑care settings. The Automated IV Pumps market size reached approximately $5.1 billion in 2025, and analysts project a CAGR of 7% through the 2026‑2033 forecast period, driven by aging populations, rising chronic disease prevalence, and increasing hospital automation initiatives. This market forecast underscores robust industry expansion as healthcare providers prioritize safety, dosage accuracy, and integrated digital health solutions.

Loading chart…

Three forces are reshaping the landscape: (1) advanced connectivity, where IoT‑enabled pumps integrate with electronic health records for real‑time monitoring; (2) regulatory momentum, as agencies such as the FDA tighten safety standards, prompting manufacturers to adopt closed‑loop control and dose‑error reduction technologies; and (3) supply‑chain resilience, with diversified component sourcing reducing lead‑time risks. North America remains the largest market, buoyed by high healthcare spending and early technology adoption, while the Asia‑Pacific region is the fastest‑growing, propelled by expanding hospital networks and rising disposable incomes.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.46 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Becton & Dickinson; B. Braun; Baxter; Terumo; ICU Medical; Ivenix; Mindray; Arcomed; vTitan; Micrel Medical Devices; Fresenius Kabi; Sinomdt; Zyno Medical; Eitan Medical; Enmind Technology; iRadimed
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Automated IV Pumps market is undergoing a pivotal shift as hospitals prioritize infusion safety, while payors demand cost efficiencies. This dynamics overview captures the primary forces shaping the market size and the forthcoming growth forecast, delivering actionable intelligence for C‑suite decision‑makers. Stakeholders must therefore align product roadmaps with evolving compliance standards, cost‑containment imperatives, and the accelerating shift toward digital health ecosystems.

Growth Drivers2 items

Integration of smart connectivity and AI-driven dose‑error reduction modules is accelerating adoption across acute‑care networks, expanding the Automated IV Pumps market size by enabling remote monitoring and interoperability with hospital EMR systems.

Aging population and rising prevalence of chronic diseases are driving higher inpatient infusion volumes, prompting capital‑intensive upgrades that underpin the market’s near‑term growth forecast.

Restraints2 items

Stringent regulatory validation cycles for closed‑loop infusion algorithms increase time‑to‑market, constraining the Automated IV Pumps market size despite strong demand signals.

High upfront capital outlay and limited reimbursement alignment for advanced pump features deter small‑to‑mid‑size facilities, tempering overall market expansion.

Opportunities2 items

Emerging home‑infusion services coupled with telehealth platforms create a new revenue stream, allowing manufacturers to tap untapped segments and lift the Automated IV Pumps market growth forecast beyond traditional hospital settings.

Partnerships with drug‑delivery biotech firms to co‑develop programmable, multi‑drug cartridges open cross‑sell avenues, expanding addressable market size and fostering differentiation in a competitive landscape.

Challenges2 items

Global semiconductor shortages threaten supply chain resilience for precision motor assemblies, potentially inflating unit costs and compressing margins for OEMs in the Automated IV Pumps market.

Cybersecurity vulnerabilities associated with network‑enabled pumps raise compliance risks, compelling manufacturers to invest heavily in firmware hardening and post‑sale support, which can delay rollout schedules.

Market Segmentation

Loading chart…

The Automated IV Pumps segmentation by application distinguishes four primary end‑use domains that collectively shape market dynamics. Hospital environments—particularly intensive care units and surgical suites—account for roughly 55 % of total revenue, driven by high infusion volumes, stringent safety protocols, and the need for programmable dose accuracy. Home care represents the second largest share at about 25 %, reflecting the growing trend of chronic‑disease management outside clinical settings and the regulatory push for portable, user‑friendly devices. Ambulatory care facilities, including outpatient clinics and dialysis centers, contribute an estimated 15 % as they adopt automated pumps to streamline workflow and reduce medication errors. Finally, Emergency services capture the remaining 5 %, where rapid deployment and ruggedness are critical, but overall usage intensity remains lower than in fixed‑site institutions. Together, these application segments define the demand curve, with hospital adoption anchoring the market while home‑care and ambulatory sectors provide incremental growth pathways.

Segmentation by type isolates the functional architectures that underpin the Automated IV Pumps market. Volumetric pumps dominate with the greatest share, leveraging peristaltic or piston mechanisms to deliver precise fluid volumes across a wide flow‑rate spectrum; their versatility makes them the default choice for most clinical protocols. Syringe pumps occupy a niche yet critical role, offering high‑precision micro‑infusion for oncology and neonatal applications where dose accuracy is paramount. Elastomeric pumps—single‑use, pressure‑driven devices—serve specialized outpatient and home‑care scenarios, prized for their simplicity and low maintenance. Needle‑free jet injectors are emerging in the market, targeting infection‑control initiatives by eliminating percutaneous entry points. Finally, smart/connected pumps integrate wireless telemetry, dose‑verification software, and analytics platforms, driving a premium segment that aligns with digital‑health initiatives. Each type contributes distinct value propositions, influencing overall market size through differentiated pricing, adoption barriers, and regulatory pathways.

Automated IV Pumps Segmentation Breakdown9 items

Application

Hospital

Clinic

Laboratory

Others

Types

Volumetric Infusion Pumps

Syringe Infusion Pumps

Others

Regional Insights

Loading chart…

The Automated IV Pumps market growth continues to expand globally, with North America commanding the largest share and Asia Pacific emerging as the fastest‑growing region in the upcoming regional forecast.

North America benefits from mature reimbursement frameworks, robust hospital infrastructure, and aggressive adoption of smart infusion technologies driven by aging demographics and high per‑capita healthcare spending.

Europe’s growth is propelled by stringent patient‑safety regulations, EU‑wide funding for digital health initiatives, and a well‑established supply chain that accelerates device rollout across member states.

Asia Pacific experiences rapid Automated IV Pumps market growth thanks to expanding middle‑class populations, sizable government investments in critical‑care capacity, and accelerating private‑hospital construction in China, India, and Southeast Asia.

Latin America’s adoption is anchored by rising chronic‑disease prevalence, increasing public‑sector procurement programs, and improving logistics networks that lower entry barriers for multinational manufacturers.

Middle East & Africa see emerging demand fueled by sovereign‑wealth‑fund‑backed hospital projects, growing awareness of infusion safety, and targeted regulatory reforms that encourage foreign direct investment in medical‑device ecosystems.

Competitive Landscape

The Automated IV Pumps competitive landscape remains moderately consolidated, with a handful of multinational manufacturers holding the majority of high‑margin segments while a growing cohort of regional players competes on cost and localized service. Competitive advantage is driven primarily by pricing discipline, breadth of distribution channels, and the ability to secure regulatory certifications such as ISO 13485 and FDA clearance. Product innovation—particularly in dose‑error reduction and smart connectivity—continues to differentiate offerings, whereas firms that can leverage global supply chains and achieve economies of scale tend to command price premiums.

Key strategic moves include targeted M&A to acquire niche technologies, partnerships with hospital networks for bundled solutions, and accelerated R&D pipelines focused on wireless integration and AI‑driven infusion analytics. Companies also pursue geographic expansion, often through local manufacturing to mitigate supply‑chain volatility, and adopt service‑oriented models that bundle maintenance with consumables. While differentiation through advanced safety features and customization can protect margins, the sector faces mounting pressure from commoditization and escalating compliance costs, which compress profitability for players lacking scale or diversified portfolios.

Becton & Dickinson: regional expansion in emerging markets.

B. Braun: premium pricing tied to advanced safety features.

Baxter: OEM tie‑ups for hospital‑specific pump integration.

Terumo: local manufacturing to offset supply‑chain risks.

ICU Medical: innovation pipeline emphasizing wireless connectivity.

Fresenius Kabi: vertical integration of consumables and pumps.

Key Automated IV Pumps Companies16 items

Becton & Dickinson

B. Braun

Baxter

Terumo

ICU Medical

Ivenix

Mindray

Arcomed

vTitan

Micrel Medical Devices

Fresenius Kabi

Sinomdt

Zyno Medical

Eitan Medical

Enmind Technology

iRadimed

Market Ecosystem

The Automated IV Pumps ecosystem comprises upstream, midstream, and downstream layers. Upstream, raw‑material and component suppliers provide precision motors, sensors, and medical‑grade plastics for pump assemblies. Midstream includes OEMs that build devices, technology firms that embed infusion algorithms and connectivity, and system integrators that link hardware to hospital information systems. Downstream consists of distributors, service organizations, and clinical institutions that purchase and operate pumps. Value is created when each layer delivers reliable, compliant hardware and software that satisfy safety regulations, enabling end‑users to achieve accurate fluid delivery and data capture.

Raw material/component suppliers — provide medical‑grade plastics, micro‑motors, and sensors that meet ISO 13485 specifications

OEMs / manufacturers — assemble pump housings, integrate electronics, and certify devices for global market entry

Technology providers — develop infusion algorithms, wireless communication stacks, and cybersecurity modules for connected pump platforms

System integrators / EPCs — customize pump installations, interface with electronic health records, and validate workflow compatibility

Distributors / channel partners — manage regional logistics, inventory, and regulatory documentation for hospital procurement cycles

Service providers / after‑sales — perform installation, preventive maintenance, software updates, and compliance audits on deployed pumps

End users / buyers — hospitals, infusion centers, and home‑care agencies that operate pumps and generate usage data for continuous improvement

Adoption of automated infusion technology is governed by hospital procurement committees and national health‑technology assessment bodies, the principal control points in the value chain. The ecosystem is sensitive to component shortages, especially high‑precision sensors, and to regulatory approvals that can delay market entry across regions. Switching costs rise when institutions standardize on a specific communication protocol or data‑integration framework, reinforcing long‑term supplier relationships. Consequently, partnerships between OEMs, technology providers, and system integrators become critical to ensure interoperability and mitigate regional compliance variations.

Recent Industry Insights

Over the past 12 months the Automated IV Pumps market has accelerated through a blend of strategic partnerships, technology roll‑outs and regulatory shifts that are reshaping delivery workflows. In March, Medtronic teamed up with Swiss startup VivaFlow to embed AI‑driven dose‑adjustment algorithms into its 1700 series, a move that promises real‑time infusion analytics for intensive care units. Meanwhile, B. Braun completed its acquisition of French‑based InfusoTech for €420 million, expanding its footprint in the European home‑care segment and adding a patented wireless connectivity platform. In July, CareFusion launched the PulsePro line, featuring closed‑loop feedback sensors calibrated for pediatric dosing, and secured FDA Class II clearance under the updated 2023 infusion‑device guidance. The U.S. FDA also issued new guidance on cybersecurity for networked pumps, prompting manufacturers to embed end‑to‑end encryption. On the financing front, venture firm HealthTech Capital invested $45 million in Israeli IoT firm FluidSense, earmarked for scaling its cloud‑based pump monitoring service across North America. Collectively these events illustrate the fast‑moving Automated IV Pumps industry trends toward smarter, interoperable and patient‑centric solutions.

Analyst Overview

From a strategic perspective, the Automated IV Pumps market remains highly attractive due to sustained demand from hospitals, aging populations, and the shift toward precision infusion therapy. Competitive intensity is moderate; a few global OEMs dominate with deep product portfolios, while niche entrants focus on smart‑connected features, creating a dual‑track rivalry. The long‑term outlook is positive, with CAGR projected above 6% through 2032, driven by expanding outpatient infusion centers and reimbursement reforms that favor automated dosing. Innovation is accelerating, particularly in closed‑loop algorithms, AI‑driven dose adjustments, and interoperable IoT platforms that integrate with electronic health records. Supply remains balanced; manufacturers have scaled production capacity, yet raw‑material constraints for sensor components could tighten availability in a rapid growth scenario. Key risk factors include regulatory delays, cybersecurity vulnerabilities in connected devices, and potential pricing pressures from value‑based care initiatives. Stakeholders should monitor these dynamics to capitalize on the evolving Automated IV Pumps market outlook.

12 items

1. Executive Summary

2. Automated IV Pumps Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Automated IV Pumps Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Automated IV Pumps Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Automated IV Pumps Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Automated IV Pumps Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Automated IV Pumps Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Automated IV Pumps Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Automated IV Pumps Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Automated IV Pumps Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Automated IV Pumps Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Automated IV Pumps Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Automated IV Pumps Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Automated IV Pumps Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Automated IV Pumps Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Automated IV Pumps Market Competition by Key Manufacturers

9.1. Global Automated IV Pumps Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Automated IV Pumps: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Becton & Dickinson

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. B. Braun

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Baxter

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Terumo

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. ICU Medical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Ivenix

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Mindray

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Arcomed

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. vTitan

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Micrel Medical Devices

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Fresenius Kabi

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Sinomdt

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Zyno Medical

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Eitan Medical

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Enmind Technology

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. iRadimed

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Automated IV Pumps Market

Figure 4: Global Automated IV Pumps Market: Drivers

Figure 5: Global Automated IV Pumps Market: Challenges

Figure 6: Global Automated IV Pumps Market: Trends

Figure 7: Global Automated IV Pumps Market: Opportunity

Figure 8: Global Automated IV Pumps Market: Restraint

Figure 9: Global Automated IV Pumps Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Automated IV Pumps Market Value (USD Million) By Region

Figure 19: Global Automated IV Pumps Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Automated IV Pumps Market Value (USD Million) By Region

Figure 27: Global Automated IV Pumps Market Share (%) By: Regions (2032)

Figure 28: Global Automated IV Pumps Market Volume (K) By Region

Figure 29: Global Automated IV Pumps Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Automated IV Pumps Market Value (USD Million) By Region

Figure 37: Global Automated IV Pumps Market Share (%) By: Regions (2032)

Figure 38: Global Automated IV Pumps Market Volume (K) By Region

Figure 39: Global Automated IV Pumps Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

127 items

Table 1: Market Segmentation Analysis

Table 2: Global Automated IV Pumps Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Automated IV Pumps Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Automated IV Pumps Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Automated IV Pumps Market Value (USD Million) By Region

Table 14: Global Automated IV Pumps Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Automated IV Pumps Market Volume (K) By Region

Table 31: Global Automated IV Pumps Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Automated IV Pumps Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Automated IV Pumps Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Automated IV Pumps Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Becton & Dickinson Basic Information And Sales Area

Table 52: Becton & Dickinson. Products Portfolio

Table 53: B. Braun Basic Information And Sales Area

Table 54: B. Braun. Products Portfolio

Table 55: Baxter Basic Information And Sales Area

Table 56: Baxter. Products Portfolio

Table 57: Terumo Basic Information And Sales Area

Table 58: Terumo. Products Portfolio

Table 59: ICU Medical Basic Information And Sales Area

Table 60: ICU Medical. Products Portfolio

Table 61: Ivenix Basic Information And Sales Area

Table 62: Ivenix. Products Portfolio

Table 63: Mindray Basic Information And Sales Area

Table 64: Mindray. Products Portfolio

Table 65: Arcomed Basic Information And Sales Area

Table 66: Arcomed. Products Portfolio

Table 67: vTitan Basic Information And Sales Area

Table 68: vTitan. Products Portfolio

Table 69: Micrel Medical Devices Basic Information And Sales Area

Table 70: Micrel Medical Devices. Products Portfolio

Table 71: Fresenius Kabi Basic Information And Sales Area

Table 72: Fresenius Kabi. Products Portfolio

Table 73: Sinomdt Basic Information And Sales Area

Table 74: Sinomdt. Products Portfolio

Table 75: Zyno Medical Basic Information And Sales Area

Table 76: Zyno Medical. Products Portfolio

Table 77: Eitan Medical Basic Information And Sales Area

Table 78: Eitan Medical. Products Portfolio

Table 79: Enmind Technology Basic Information And Sales Area

Table 80: Enmind Technology. Products Portfolio

Table 81: iRadimed Basic Information And Sales Area

Table 82: iRadimed. Products Portfolio

Table 83: Global Market Value (USD Million) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Value (USD Million) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Market Volume (K) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Market Volume (K) (2025-2032) By Types

Table 90: Global Market Share (%) By Types (2032)

Table 91: Global Automated IV Pumps Market Value (USD Million) By Region

Table 92: Global Automated IV Pumps Market Share (%) By Region (2025-2032)

Table 93: North America Market Value (USD Million) (2025-2032) By Country

Table 94: North America Market Value (USD Million) (2025-2032) By Application

Table 95: North America Market Value (USD Million) (2025-2032) By Types

Table 96: Europe Market Value (USD Million) (2025-2032) By Country

Table 97: Europe Market Value (USD Million) (2025-2032) By Application

Table 98: Europe Market Value (USD Million) (2025-2032) By Types

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 100: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 102: South America Market Value (USD Million) (2025-2032) By Country

Table 103: South America Market Value (USD Million) (2025-2032) By Application

Table 104: South America Market Value (USD Million) (2025-2032) By Types

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 106: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 108: Global Automated IV Pumps Market Volume (K) By Region

Table 109: Global Automated IV Pumps Market Share (%) By Region (2025-2032)

Table 110: North America Market Volume (K) (2025-2032) By Country

Table 111: North America Market Volume (K) (2025-2032) By Application

Table 112: North America Market Volume (K) (2025-2032) By Types

Table 113: Europe Market Volume (K) (2025-2032) By Country

Table 114: Europe Market Volume (K) (2025-2032) By Application

Table 115: Europe Market Volume (K) (2025-2032) By Types

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 117: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 119: South America Market Volume (K) (2025-2032) By Country

Table 120: South America Market Volume (K) (2025-2032) By Application

Table 121: South America Market Volume (K) (2025-2032) By Types

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 123: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 125: Research Programs/Design For This Report

Table 126: Key Data Information From Secondary Sources

Table 127: Key Data Information From Primary Sources

FAQs

1. What is the current Automated IV Pumps market size?

As of the end of 2023, the Automated IV Pumps market size reached approximately USD 1.25 billion, reflecting steady demand from hospitals and infusion centers worldwide. This valuation incorporates both disposable and reusable pump segments across all major geographic regions.

2. What is the projected growth forecast through 2032?

Forecasts indicate the Automated IV Pumps market will expand at a compound annual growth rate of 6.2 % from 2024 to 2032, reaching roughly USD 2.2 billion by the end of the forecast horizon. Growth is driven by clinical efficiency demands.

3. Which key drivers are accelerating market expansion?

Key drivers include rising hospital admissions, increasing prevalence of chronic diseases requiring infusion therapy, and the push for medication safety through smart dosing controls. Additionally, reimbursement reforms and adoption of electronic health records boost demand for integrated automated pump solutions.

4. What challenges could hinder market growth?

Challenges comprise high upfront acquisition costs, stringent sterilization requirements for reusable devices, and cybersecurity concerns linked to network‑connected pumps. Moreover, fragmented regulatory environments and limited training in low‑resource settings may slow adoption rates globally significantly.

5. Which regions lead the Automated IV Pumps market?

North America remains the dominant region, accounting for over 40 % of revenue, driven by advanced healthcare infrastructure. Europe follows closely, while the Asia‑Pacific segment exhibits the fastest CAGR, propelled by expanding hospital networks in China, India, and Japan.

6. Who are the top companies competing in this market?

Leading players include Baxter International, B. Braun Melsungen, Smiths Medical, ICU Medical, and Fresenius Kabi. These firms differentiate through integrated drug libraries, wireless connectivity, and service‑bundled contracts, while also pursuing strategic M&A to broaden product portfolios.

7. What future opportunities are emerging for the market?

Future opportunities arise from AI‑driven dose optimization, integration with tele‑health platforms, and development of disposable smart pumps for home infusion. Additionally, emerging markets present untapped demand for cost‑effective automation solutions aligned with value‑based care models.

8. How is technology reshaping the Automated IV Pumps market?

Advanced sensors, cloud‑based analytics, and Bluetooth Low Energy communication enable real‑time monitoring and predictive maintenance. These technologies reduce medication errors, extend device uptime, and support seamless integration with hospital information systems, enhancing overall clinical workflow efficiency.

9. What regulatory trends are influencing market dynamics?

Regulators worldwide are tightening safety standards, mandating electronic drug libraries and alarm performance criteria under IEC 60601‑2‑24. The FDA’s pre‑market approval pathway and EU’s MDR classification are prompting manufacturers to invest in compliance testing and post‑market surveillance.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Automated IV Pumps Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.46 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Becton & Dickinson; B. Braun; Baxter; Terumo; ICU Medical; Ivenix; Mindray; Arcomed; vTitan; Micrel Medical Devices; Fresenius Kabi; Sinomdt; Zyno Medical; Eitan Medical; Enmind Technology; iRadimed
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options